3/11
08:30 am
inbs
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
Low
Report
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
2/21
04:05 pm
inbs
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
Low
Report
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
2/20
08:30 am
inbs
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
Low
Report
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
2/19
04:42 pm
inbs
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
Medium
Report
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
2/13
08:30 am
inbs
Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
Medium
Report
Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
2/10
08:30 am
inbs
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
Medium
Report
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
2/7
08:30 am
inbs
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
Medium
Report
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
2/6
09:00 am
inbs
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
Medium
Report
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
1/31
09:00 am
inbs
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
Medium
Report
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
1/30
09:00 am
inbs
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
Medium
Report
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
1/29
09:00 am
inbs
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
Low
Report
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
1/28
09:00 am
inbs
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
High
Report
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
1/14
08:30 am
inbs
Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites
Medium
Report
Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites
12/18
08:30 am
inbs
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
High
Report
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology